Clinical digital twin platform
Open for applications
Clinical digital twin platform
21-100 employees
Open for applications
21-100 employees
To help create a world in which no lives are lost to treatable diseases, shaping healthier and safer future generations.
Desirable
Sam Franklin
CEO of Otta
Health tracking has peaked intrigue in millions of Americans, but currently available software and hardware are limited. Software generally works through manual data entry or wearable hardware with siloed functions and doesn't consider the complex data of an individual’s body.
Q Bio creates innovative healthcare hardware and software that aims to track individuals’ bodily data to create what it calls a 'digital twin'. Through full-body tracking hardware and comprehensive datasets, the startup aims to track changes to a user's body over time and use this to deliver valuable and scalable insights about a user's health.
The company stands out from other health-tracking services in two key ways - it approaches bodily tracking from both a granular perspective, in addition to a scalable and long-term perspective. What's more, through visualizing data sets as a 'digital twin', Q Bio provides insights that are relatable and understandable.
7% employee growth in 12 months
Jul 2024
$27m
LATE VC
Mar 2020
$40m
SERIES B
San Carlos, CA
Founders
Jeffrey Kaditz
(CEO)They studied at Carnegie Mellon University before spending 2 years at DeNA and 4 years at Affirm, Inc. They left their Board Member role to found Q Bio in May 2015, serving since as CEO.
Share this job
View 4 more jobs at Q Bio